Eco Animal Health Group PLC Deferred Share Option Awards (5871J)
December 13 2022 - 10:50AM
UK Regulatory
TIDMEAH
RNS Number : 5871J
Eco Animal Health Group PLC
13 December 2022
13 December 2022
ECO Animal Health Group plc
("ECO" or the "Company")
Deferred Share Option Awards to Executive Director &
PDMRs
ECO Animal Health Group plc announces that on 12 December 2022,
deferred nominal cost share options were granted under the
Company's Deferred Bonus Plan ("DBS") over 45,606 ordinary shares
in the Company (representing approximately 0.07 percent of the
Company's issued share capital) to an Executive Director and
members of the Company's Executive Leadership Team ("ELT") listed
below. These awards relate to the deferral of 33% and 20% of the
annual bonus for Executive Directors and members of ELT
respectively earned in respect of the Company's financial year
ended 31 March 2022.
Name Position Number of Deferred
Share Options
Chris Wilks Chief Financial Officer 4,309
------------------------------------ -------------------
Head of Global Research and
Hafid Benchaoui Development 3,666
------------------------------------ -------------------
Business Unit Head - China
Andrew Buglass & Japan 6,872
------------------------------------ -------------------
Seamus Long Global Director of Operations 2,260
------------------------------------ -------------------
Jordi Mora Global Technical Services Director 4,507
------------------------------------ -------------------
Piotr Postepski Global Director of Sales 14,926
------------------------------------ -------------------
Oscar Romero-Galindo Head of Global Marketing 9,066
------------------------------------ -------------------
As indicated in the Circular to shareholders dated 4 February
2021, the DBS has been established to allow the Remuneration
Committee to require a significant part of the annual bonuses paid
to Executive Directors and senior management to be deferred in
exchange for an award of nominal cost options which vest after 3
years.
For further information please contact:
ECO Animal Health Group plc
David Hallas (CEO) 020 8447
Christopher Wilks (CFO) 8899
IFC Advisory
Graham Herring 020 3934
Zach Cohen 6630
Singer Capital Markets (Nominated Adviser
& Joint Broker)
Phil Davies 020 7496
George Tzimas 3000
Investec (Joint Broker)
Gary Clarence
Daniel Adams 020 7597
Carlo Spingardi 5970
Equity Developments
Hannah Crowe 020 7065
Matt Evans 2692
About ECO Animal Health
ECO Animal Health Group plc researches, develops and
commercialises products for livestock. Our business
strategy is to generate shareholder value by achieving
the maximum sales potential from the existing product
portfolio whilst investing in Research and Development
("R&D") for new products, particularly vaccines, and
seeking to in-license new products.
PDMR Notification - ECO DBS Deferred Share Option Awards
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name 1. Chris Wilks
2. Hafid Benchaoui
3. Andrew Buglass
4. Seamus Long
5. Jordi Mora
6. Piotr Postepski
7. Oscar Romero-Galindo
======================= ==================================================
2. Reason for the notification
===========================================================================
a. Position/status 1. Chief Financial Officer
2. Head of Global Research and Development
3. Business Unit Head - China & Japan
4. Global Director of Operations
5. Global Technical Services Director
6. Global Director of Sales
7. Head of Global Marketing
======================= ==================================================
b. Initial notification Initial notification
/Amendment
======================= ==================================================
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
===========================================================================
a. Name Eco Animal Health Group Plc
======================= ==================================================
b. LEI 2138009XN9DJ3YP70B55
======================= ==================================================
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
===========================================================================
a. Description Options over ordinary shares of 5p each.
of the
Financial instrument, GB0032036807
type of instrument
Identification
code
======================= ==================================================
b. Nature of the Award of nominal cost share options under
transaction the Company's DBS.
======================= ==================================================
c. Price(s) and Numbers 1 to 7 in the left-hand column correspond
volume(s) to the relevant PDMR as detailed in boxes
1a and 2a above.
Price(s) Volume(s)
1. 5p 4,309
----------
2. 5p 3,666
----------
3. 5p 6,872
----------
4. 5p 2,260
----------
5. 5p 4,507
----------
6. 5p 14,926
----------
7. 5p 9,066
----------
======================= ==================================================
d. Aggregated
information
Aggregated n/a
volume
Price
======================= ==================================================
e. Date of the 12 December 2022
transaction
======================= ==================================================
f. Place of the Outside a trading venue.
transaction
======================= ==================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHGPGMCPUPPGAW
(END) Dow Jones Newswires
December 13, 2022 10:50 ET (15:50 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024
